Safety for today’s patient-directed care.1,2
Spinosad Topical Suspension 0.9% active compound, spinosad, exhibits no systemic absorption, no toxicities and no lab abnormalities.See the safety data
A proven therapy for pediatric patients 4 years of age and older.2
Prescription data indicates that 29% of all scabies prescriptions in the US are for children under the age of 18 years.3 The safety and efficacy of Spinosad Topical Suspension 0.9% have been established in pediatric patients (165) who are four (4) years of age and older.1-3
- Data on file, ParaPRO, LLC.
- Spinosad Topical Suspension 0.9% Prescribing Information.
- IQVIA July 16,2021.
- Khalil S et al. PLoS Negl Trop Dis. 2017;11(11): e0005920.
- Jackson SM, et. al: Pathobiology of the stratum corneum. West J Med 1993 Mar; 158:279-285).